CN3865285
Active
Amendment A2
Pharmaceutical Benefits Scheme Price Disclosure Data and Stockholding Administration
$4.6M
Contract Value
Contract Details
- Contract ID
- CN3865285
- Status
- active
- Financial Year
- FY26
- Category
- Engineering and Research Services(UNSPSC: 81112000)
Key Dates
- Publish Date
- 30 June 2026
- Signed Date
- 14 Apr 2022
- Start Date
- 30 June 2022
- End Date
- 29 June 2027
- Duration
- 5 years, 1 month
Procurement Information
- Procurement Method
- Open tender
Contract History
This contract has been amended 2 times. Currently showing amendment A2.
Original Contract
Published 14 Apr 2022 · 30 June 2022 to 29 June 2027
$1.8M
Amendment A1
Published 30 June 2026 · 30 June 2022 to 29 June 2027
$3.7M
+$1.8M
Amendment A2
Current
Published 30 June 2026 · 30 June 2022 to 29 June 2027
$4.6M
+$917K
Supplier
AUSTRALIAN HEALTHCARE ASSOCIATES PTY. LTD.
- ABN
- 82 072 790 848
- Entity Type
- Australian Private Company
- Location
- VIC
Agency
More from AUSTRALIAN HEALTHCARE ASSOCIATES PTY. LTD.
Opiod Dependence Treatment Pharmacy Program Task Monies
$198.4MDepartment of Health, Disability and Ageing
Regional Pharmacy Transition Allowance for 60-day Prescriptions
$148.2MDepartment of Health and Aged Care
Fee to Chemotherapy Compounders
$112.0MDepartment of Health, Disability and Ageing
Vaccinations in Pharmacy Program
$108.4MDepartment of Health, Disability and Ageing
Program Administrator/s to Support the Community Service Obligation (CSO) (CSO Funding Pool and CSO & National Diabetes Services Scheme (NDSS) Services) and the Chemotherapy Compounding Payment Scheme (CCPS)
$75.0MDepartment of Health, Disability and Ageing